Virus Inactivation of Fresh Frozen Plasma by a Solvent Detergent Procedure: Biological Results

Vox Sanguinis

Volumn 63, Issue 4, 1992, Pages 251-256

  Piquet, Y ^a   Janvier, G ^b   Selosse, P ^c   Doutremepuich, C ^d   Jouneau, J ^a   Nicolle, G ^a   Platel, D ^a   Vezon, G ^a  

^a Centre de Transfusion Sanguine   (France)

^b HÔPITAL PELLEGRIN   (France)

^c Octapharma AG Lachen   (Switzerland)

^d Faculté de Pharmacie de Bordeaux ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8C; CASTOR OIL; DETERGENT; FRESH FROZEN PLASMA; OCTOXINOL; POTASSIUM; PROTEIN;

ARTICLE; BLOOD LEVEL; BLOOD PH; CHROMATOGRAPHY; HUMAN; METHODOLOGY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PURIFICATION; VIRUS INACTIVATION;

BLOOD COAGULATION FACTORS; BLOOD TRANSFUSION; HEPACIVIRUS; HEPATITIS B VIRUS; HIV; HUMAN; OCTOXYNOL; PHOSPHORIC ACID ESTERS; PLASMA; POLYETHYLENE GLYCOLS; QUALITY CONTROL; VIRUS ACTIVATION;

EID: 0026493740     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1992.tb01230.x     Document Type: Article

References (28)

1. Chemical, clinical and immunological studies on products of human plasma fractionation: Inactivation of virus of homologous serum albumin by means of heat
2. Reduction risk of hepatitis transmission by heat treatment of a human factor VIII concentrate
3. Virus sterilization of plasma protein by treatment with solvent/detergent mixtures (abstract). Satellite Symp 11th Int Cong on Thrombosis and Haemostasis
4. Inactivation of the AIDS causing retroviruses and other human viruses in antihemophilic plasma protein preparations by pasteurization
5. Clinical evaluation of the hepatitis safety of a β‐propiolactone/ultraviolet treated factor IX concentrate (PPSB)
6. The use of Tri‐n‐Butyl phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation
7. Solvent/detergent treated plasma: A virus inactivated substitute for fresh frozen plasma
8. The assay of antihemophilic globulin activity
9. Etude analytique des temps de Quick allongés. Dosage de pro‐thrombine, de proconvertine et de pro‐accélérine
10. Heparin cofactor activity measured with an amidolytic method
11. Gerinnungsphysiologische Schnell‐methode 2 zur Bestimmung des Fibrinogens
12. Ristocetin: A new tool in the investigation of platelet aggregation
13. Factor VIII related antigen: Measurement by enzyme immunoassay
14. Experimental venous thrombosis in rats treated with heparin and a low molecular weight heparin fraction
15. Automa‐tisation de l'étude de l'hémostase et de la fibri‐nolyse par les substrats chromogéniques
16. Application of enzyme immunoassays to coagulation testing
17. Determination of serum protein by means of the biuret reaction
18. Substitute of a non‐hazardous chromogen for benzidine in the measurement of plasma haemoglobin
19. Inactivation of virus in labile blood derivates. I. Disruption of lipid‐enveloped virus by tri‐n‐butyl‐phosphate/detergent combinations
20. Quantitative endotoxin determination in blood with a chromogenic substrate
21. What are the critical factors in the production and quality control of frozen plasma intended for direct transfusion or for fractionation to provide medically needed labile coagulation factors?
22. Changes in plasma coagulation factors during blood storage
23. Membrane and lipid involvement in blood coagulation
24. Use of laser UV for inactivation of virus in blood products
25. Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors
26. A novel method for removal of human immunodeficiency virus: Filtration with porous polymeric membranes
27. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light